1Conlon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[J]. J Exp Zool, 1996,275 (2-3):226-238.
2Ames RS, Sarau HM, Chambers JK, et al. Human urotensin Ⅱ is a potent vasoconstrictor and agonist for the orphan receptorGPR14[J]. Nature, 1999,401(6750): 282-286.
4Le-Mevel JC, Olson KR, Conklin D, et al. Cardiovascular action of trout urotensin Ⅱ in the conscious trout,oncorhynchus mykiss [J]. Am J Physiol, 1996, 271 (5):R1335-R1343.
5Lu Y, Zou CJ, Huang DW, et al. Cardiovascular effects of urotensin Ⅱ in different brain areas[J]. Peptides, 2002, 23(9): 1631-1635.
6Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord[J]. Proc Natl Acad Sci USA, 1998,95(26):15803-15808.
7Mori M, Sugo T, Abe M, et al. Human urotensin Ⅱ is the endogenous ligand of a G-protein coupled receptor SENR(GPR14)[J]. Biochem Biophys Res Commun, 1999,265(1):123-129.
8Chartel N, Conlon JM, Collin F, et al. Urotensin Ⅱ in the central nervous system of the frog Rana ridibunda.Immunohistochemical localization and Biochemical characterization[J]. J CompNeurol, 1996,364(2):324-339.
9Marchese A, Heiber M, Nguyen T, et al. Cloning and chromosomal mapping of three novel genes, GPR9. GPR10and GPR14, encoding receptors related to interleukin 8,neuropeptide Y, and somatostatin receptors[J]. Genomics,1995,29(12) :335-344.
10Liu Q, Pong SS, Zeng Z, et al. Identification of urotensinⅡ as the endogenous ligand for the orphan G protein coupled receptor GPR14[J]. Biochem Biophys Res Commun, 1999,266(1) :174-178.
2[1]Ames RS, Sarau HM, Chambers JK, et al.Human urotensin-Ⅱis a potent vasoconstrictor and agonist for the orphan receptor GPR14[J].Nature, 1999, 401:282-286.
3[2]Mori M, Sugo T, Abe M, et al.UrotensinⅡis the endogenous ligand of a G-protein-coupled orphan receptor, SENR(GPR14)[J].Biochem Biophys Res Commun, 1999, 265(1): 123-129.
4[3]Marchese A, Heiber M, Nguyen T, et al.Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8,neuropeptide Y, and somatostatin receptor[J].Genomic, 1995, 29:335-344.
5[4]Liu QY, Pong SS, Zeng ZZ, et al.Identification of urotensin Ⅱas the endogenous ligand for the orphan G-protein-coupled receptor GPR14[J].Biochem Biophys Res Commun, 1999, 266(1): 174-178.
6[5]Maguire JJ,Kuc RE,Davenport AP.Orphan-receptor ligand human urotensinⅡ: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1[J].Br J Pharmacol, 2000, 131(3):441-446.
8[7]Gartlon J, Parker F, Harrison DC, et al.Central effects of urotensin-Ⅱfollowing ICV administration in rats[J].Psychopharmacology (Berl), 2001,155(4): 426-433.
9[8]Douglas SA, Ohlstein EH.Human urotensin-Ⅱ, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease[J].Trends Cardiovasc Med, 2000,10(6): 229-237.
2MATSUSHITA M, SHICHIRI M, LMAI T, et al. Co-expression of umtensin Ⅱ and its receptor (GPR14) in human cardiovascular and renal tissues [ J ]. J Hypertens ,2001,19 (7) :2185 - 2190.
3LANGHAM RG, KELLY DJ, GOW RM, et al. Increased expression of urotensin Ⅱ and urotensin Ⅱ receptor in humna diabetic nephropathy [ J ]. Am J Kidney Dis,2004,44 ( 5 ) : 826 - 831.
4BARRETrE PO, SCHWERTANI AG. A closer look at the role of urotensin Ⅱ in the metabolic syndrome [ J ]. Front Endocnnol ( Lausanne ) ,2012,3 : 165.
5LANGHAM RG, KELLY DJ. Urotensin Ⅱ and the kidney [ J ]. Curr Opin Nephrol Hypertens, 2013 ,22( 1 ) :107 -112.
6HURSITOGLU M, TUKEK T, CIKRIKCIOGLU MA, et al. Urotensin Ⅱ levels in patients with chronic kidney disease and kidney transplants[ J]. Ups J Med Sci, 2012,117 (1) :22 -27.
7TAKAHASHI K, HIROSE T, MORI N, et al. The renin- angiotensin system, adrenomedullins and urotensin Ⅱ in the kidney: possible renoprotection via the kidney peptide systems [ J ]. Peptides ,2009,30 ( 8 ) : 1575 - 1585.
8CLOZEL M, BINKERT C, BIRKER-ROBACZEWSKA M, et al. Pharmacology of the urotensin-Ⅱ receptor antagonist palosuran: first demonstration of apathophysiological role of the urotensin system [ J ]. J Pharmacol Exp Ther,2004,311 ( 1 ) :204 - 212.
9MANUCHA W, VALLES PG. Apoptosis modulated by oxidative stress and inflammation during obstructive nephropathy [ J ]. Inflamm Allergy Drug Targets, 2012,11 (4) : 303 - 312.
10NAM HK, LEE S J, KIM MH, et al. Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporineinduced nephropathy [ J ]. Am J Nephrol, 2013,37 (1):7-15.
